| UniProt ID | ENSA_HUMAN | |
|---|---|---|
| UniProt AC | O43768 | |
| Protein Name | Alpha-endosulfine | |
| Gene Name | ENSA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 121 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-67 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase (By similarity). Also acts as a stimulator of insulin secretion by interacting with sulfonylurea receptor (ABCC8), thereby preventing sulfonylurea from binding to its receptor and reducing K(ATP) channel currents.. | |
| Protein Sequence | MSQKQEEENPAEETGEEKQDTQEKEGILPERAEEAKLKAKYPSLGQKPGGSDFLMKRLQKGQKYFDSGDYNMAKAKMKNKQLPSAGPDKNLVTGDHIPTPQDLPQRKSSLVTSKLAGGQVE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSQKQEEEN ------CCHHHHCCC | 46.19 | 21406692 | |
| 2 | Phosphorylation | ------MSQKQEEEN ------CCHHHHCCC | 46.19 | 29255136 | |
| 2 (in isoform 3) | Phosphorylation | - | 46.19 | 27251275 | |
| 4 | Ubiquitination | ----MSQKQEEENPA ----CCHHHHCCCHH | 52.98 | 33845483 | |
| 14 | Phosphorylation | EENPAEETGEEKQDT CCCHHHHCCCHHHHH | 41.20 | 21815630 | |
| 21 | Phosphorylation | TGEEKQDTQEKEGIL CCCHHHHHHHHCCCC | 35.81 | 23186163 | |
| 24 | Ubiquitination | EKQDTQEKEGILPER HHHHHHHHCCCCHHH | 51.96 | 24816145 | |
| 34 | Ubiquitination | ILPERAEEAKLKAKY CCHHHHHHHHHHHCC | 50.55 | 24816145 | |
| 36 | Ubiquitination | PERAEEAKLKAKYPS HHHHHHHHHHHCCCC | 54.52 | 32142685 | |
| 38 | Ubiquitination | RAEEAKLKAKYPSLG HHHHHHHHHCCCCCC | 41.97 | 24816145 | |
| 40 | Acetylation | EEAKLKAKYPSLGQK HHHHHHHCCCCCCCC | 56.99 | 25953088 | |
| 40 | Ubiquitination | EEAKLKAKYPSLGQK HHHHHHHCCCCCCCC | 56.99 | 32142685 | |
| 41 | Phosphorylation | EAKLKAKYPSLGQKP HHHHHHCCCCCCCCC | 11.69 | 22115753 | |
| 43 | Phosphorylation | KLKAKYPSLGQKPGG HHHHCCCCCCCCCCC | 41.88 | 23401153 | |
| 43 | Ubiquitination | KLKAKYPSLGQKPGG HHHHCCCCCCCCCCC | 41.88 | 32015554 | |
| 43 (in isoform 3) | Phosphorylation | - | 41.88 | 27251275 | |
| 47 | Acetylation | KYPSLGQKPGGSDFL CCCCCCCCCCCCHHH | 43.78 | 25953088 | |
| 47 | Ubiquitination | KYPSLGQKPGGSDFL CCCCCCCCCCCCHHH | 43.78 | 32015554 | |
| 51 | Phosphorylation | LGQKPGGSDFLMKRL CCCCCCCCHHHHHHH | 30.98 | 27794612 | |
| 52 | Ubiquitination | GQKPGGSDFLMKRLQ CCCCCCCHHHHHHHH | 43.93 | 32015554 | |
| 55 | Sulfoxidation | PGGSDFLMKRLQKGQ CCCCHHHHHHHHHCC | 2.10 | 21406390 | |
| 56 | Methylation | GGSDFLMKRLQKGQK CCCHHHHHHHHHCCC | 52.70 | - | |
| 56 | Ubiquitination | GGSDFLMKRLQKGQK CCCHHHHHHHHHCCC | 52.70 | 23000965 | |
| 59 | Acetylation | DFLMKRLQKGQKYFD HHHHHHHHHCCCHHC | 52.44 | 19608861 | |
| 59 | Ubiquitination | DFLMKRLQKGQKYFD HHHHHHHHHCCCHHC | 52.44 | 21890473 | |
| 59 (in isoform 5) | Ubiquitination | - | 52.44 | 21890473 | |
| 59 (in isoform 6) | Ubiquitination | - | 52.44 | 21890473 | |
| 59 (in isoform 7) | Phosphorylation | - | 52.44 | - | |
| 60 | Ubiquitination | FLMKRLQKGQKYFDS HHHHHHHHCCCHHCC | 68.82 | 23000965 | |
| 63 | Acetylation | KRLQKGQKYFDSGDY HHHHHCCCHHCCCCH | 57.46 | 23954790 | |
| 63 | Phosphorylation | KRLQKGQKYFDSGDY HHHHHCCCHHCCCCH | 57.46 | 32645325 | |
| 63 | Ubiquitination | KRLQKGQKYFDSGDY HHHHHCCCHHCCCCH | 57.46 | 23000965 | |
| 63 (in isoform 1) | Ubiquitination | - | 57.46 | 21890473 | |
| 63 (in isoform 2) | Ubiquitination | - | 57.46 | 21890473 | |
| 63 (in isoform 3) | Phosphorylation | - | 57.46 | - | |
| 63 (in isoform 9) | Phosphorylation | - | 57.46 | - | |
| 64 | Phosphorylation | RLQKGQKYFDSGDYN HHHHCCCHHCCCCHH | 12.53 | 22167270 | |
| 67 | Phosphorylation | KGQKYFDSGDYNMAK HCCCHHCCCCHHHHH | 24.54 | 19664994 | |
| 70 | Phosphorylation | KYFDSGDYNMAKAKM CHHCCCCHHHHHHHH | 15.46 | 25463755 | |
| 70 | Ubiquitination | KYFDSGDYNMAKAKM CHHCCCCHHHHHHHH | 15.46 | 21890473 | |
| 72 | Sulfoxidation | FDSGDYNMAKAKMKN HCCCCHHHHHHHHHC | 3.09 | 30846556 | |
| 74 | Acetylation | SGDYNMAKAKMKNKQ CCCHHHHHHHHHCCC | 37.46 | 25953088 | |
| 74 | Ubiquitination | SGDYNMAKAKMKNKQ CCCHHHHHHHHHCCC | 37.46 | 32015554 | |
| 76 | Ubiquitination | DYNMAKAKMKNKQLP CHHHHHHHHHCCCCC | 50.10 | 29967540 | |
| 76 (in isoform 7) | Phosphorylation | - | 50.10 | 25159151 | |
| 79 | Phosphorylation | MAKAKMKNKQLPSAG HHHHHHHCCCCCCCC | 33.53 | 32142685 | |
| 79 (in isoform 7) | Phosphorylation | - | 33.53 | 22496350 | |
| 80 | Ubiquitination | AKAKMKNKQLPSAGP HHHHHHCCCCCCCCC | 47.93 | 29967540 | |
| 80 (in isoform 3) | Phosphorylation | - | 47.93 | 25159151 | |
| 80 (in isoform 9) | Phosphorylation | - | 47.93 | 25159151 | |
| 82 (in isoform 7) | Phosphorylation | - | 3.75 | 25159151 | |
| 83 | Phosphorylation | KMKNKQLPSAGPDKN HHHCCCCCCCCCCCC | 21.46 | 32142685 | |
| 83 (in isoform 3) | Phosphorylation | - | 21.46 | 22496350 | |
| 83 (in isoform 9) | Phosphorylation | - | 21.46 | 22496350 | |
| 84 | O-linked_Glycosylation | MKNKQLPSAGPDKNL HHCCCCCCCCCCCCC | 55.22 | OGP | |
| 84 | Phosphorylation | MKNKQLPSAGPDKNL HHCCCCCCCCCCCCC | 55.22 | 20068231 | |
| 85 | Ubiquitination | KNKQLPSAGPDKNLV HCCCCCCCCCCCCCC | 31.43 | 29967540 | |
| 86 | Ubiquitination | NKQLPSAGPDKNLVT CCCCCCCCCCCCCCC | 34.96 | 21890473 | |
| 86 (in isoform 3) | Phosphorylation | - | 34.96 | 25159151 | |
| 86 (in isoform 7) | Ubiquitination | - | 34.96 | 21890473 | |
| 86 (in isoform 9) | Phosphorylation | - | 34.96 | 25159151 | |
| 89 | Acetylation | LPSAGPDKNLVTGDH CCCCCCCCCCCCCCC | 56.14 | 25953088 | |
| 89 | Ubiquitination | LPSAGPDKNLVTGDH CCCCCCCCCCCCCCC | 56.14 | 29967540 | |
| 90 | Ubiquitination | PSAGPDKNLVTGDHI CCCCCCCCCCCCCCC | 47.31 | 21890473 | |
| 90 (in isoform 3) | Ubiquitination | - | 47.31 | 21890473 | |
| 90 (in isoform 4) | Phosphorylation | - | 47.31 | 22496350 | |
| 92 | Ubiquitination | AGPDKNLVTGDHIPT CCCCCCCCCCCCCCC | 8.64 | 29967540 | |
| 93 | O-linked_Glycosylation | GPDKNLVTGDHIPTP CCCCCCCCCCCCCCC | 39.81 | 31373491 | |
| 93 | Phosphorylation | GPDKNLVTGDHIPTP CCCCCCCCCCCCCCC | 39.81 | 26074081 | |
| 93 (in isoform 4) | Phosphorylation | - | 39.81 | 27155012 | |
| 96 | Ubiquitination | KNLVTGDHIPTPQDL CCCCCCCCCCCCCCC | 29.31 | 29967540 | |
| 97 (in isoform 4) | Ubiquitination | - | 4.90 | 21890473 | |
| 99 | O-linked_Glycosylation | VTGDHIPTPQDLPQR CCCCCCCCCCCCCCH | 32.74 | 30838711 | |
| 99 | Phosphorylation | VTGDHIPTPQDLPQR CCCCCCCCCCCCCCH | 32.74 | 25159151 | |
| 100 (in isoform 3) | Phosphorylation | - | 21.97 | 27251275 | |
| 101 | Ubiquitination | GDHIPTPQDLPQRKS CCCCCCCCCCCCHHH | 68.31 | 29967540 | |
| 103 | Ubiquitination | HIPTPQDLPQRKSSL CCCCCCCCCCHHHHH | 3.07 | 29967540 | |
| 104 (in isoform 6) | Phosphorylation | - | 39.97 | 25849741 | |
| 105 | Phosphorylation | PTPQDLPQRKSSLVT CCCCCCCCHHHHHHH | 73.13 | 32142685 | |
| 105 | Ubiquitination | PTPQDLPQRKSSLVT CCCCCCCCHHHHHHH | 73.13 | 29967540 | |
| 105 (in isoform 6) | Phosphorylation | - | 73.13 | 25849741 | |
| 107 | Ubiquitination | PQDLPQRKSSLVTSK CCCCCCHHHHHHHHH | 38.87 | 29967540 | |
| 108 | Phosphorylation | QDLPQRKSSLVTSKL CCCCCHHHHHHHHHH | 30.97 | 27273156 | |
| 108 (in isoform 2) | Phosphorylation | - | 30.97 | 25849741 | |
| 108 (in isoform 6) | Phosphorylation | - | 30.97 | 17924679 | |
| 109 | Phosphorylation | DLPQRKSSLVTSKLA CCCCHHHHHHHHHHC | 29.87 | 23927012 | |
| 109 (in isoform 2) | Phosphorylation | - | 29.87 | 25849741 | |
| 109 (in isoform 6) | Phosphorylation | - | 29.87 | 19651622 | |
| 110 | Ubiquitination | LPQRKSSLVTSKLAG CCCHHHHHHHHHHCC | 6.68 | 24816145 | |
| 112 | Phosphorylation | QRKSSLVTSKLAGGQ CHHHHHHHHHHCCCC | 25.99 | 30266825 | |
| 112 (in isoform 2) | Phosphorylation | - | 25.99 | 17924679 | |
| 113 | Phosphorylation | RKSSLVTSKLAGGQV HHHHHHHHHHCCCCC | 20.42 | 23927012 | |
| 113 (in isoform 2) | Phosphorylation | - | 20.42 | 19651622 | |
| 114 | Acetylation | KSSLVTSKLAGGQVE HHHHHHHHHCCCCCC | 32.75 | 25953088 | |
| 114 | Ubiquitination | KSSLVTSKLAGGQVE HHHHHHHHHCCCCCC | 32.75 | 24816145 | |
| 115 (in isoform 3) | Phosphorylation | - | 5.54 | 27251275 | |
| 119 | Ubiquitination | TSKLAGGQVE----- HHHHCCCCCC----- | 34.94 | 29967540 | |
| 121 | Phosphorylation | KLAGGQVE------- HHCCCCCC------- | 47.20 | 32142685 | |
| 123 | Ubiquitination | AGGQVE--------- CCCCCC--------- | 29967540 | ||
| 124 (in isoform 3) | Phosphorylation | - | 27251275 | ||
| 124 (in isoform 9) | Phosphorylation | - | 25849741 | ||
| 125 | Phosphorylation | GQVE----------- CCCC----------- | 32142685 | ||
| 125 (in isoform 3) | Phosphorylation | - | 27251275 | ||
| 125 (in isoform 9) | Phosphorylation | - | 25849741 | ||
| 126 | Ubiquitination | QVE------------ CCC------------ | 24816145 | ||
| 128 (in isoform 9) | Phosphorylation | - | 17924679 | ||
| 129 (in isoform 9) | Phosphorylation | - | 19651622 | ||
| 130 | Ubiquitination | ---------------- ---------------- | 24816145 | ||
| 131 (in isoform 4) | Phosphorylation | - | 25849741 | ||
| 132 (in isoform 4) | Phosphorylation | - | 25849741 | ||
| 135 (in isoform 4) | Phosphorylation | - | 17924679 | ||
| 136 (in isoform 4) | Phosphorylation | - | 19651622 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 67 | S | Phosphorylation |
| 9653196 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ENSA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MCM3_HUMAN | MCM3 | physical | 17353931 | |
| OFD1_HUMAN | OFD1 | physical | 28514442 | |
| RPP25_HUMAN | RPP25 | physical | 28514442 | |
| DPP9_HUMAN | DPP9 | physical | 28514442 | |
| PEX6_HUMAN | PEX6 | physical | 28514442 | |
| UBB_HUMAN | UBB | physical | 28514442 | |
| QSOX1_HUMAN | QSOX1 | physical | 28514442 | |
| UBP4_HUMAN | USP4 | physical | 28514442 | |
| CBX5_HUMAN | CBX5 | physical | 28514442 | |
| IREB2_HUMAN | IREB2 | physical | 28514442 | |
| DD19B_HUMAN | DDX19B | physical | 28514442 | |
| POP7_HUMAN | POP7 | physical | 28514442 | |
| AT12A_HUMAN | ATP12A | physical | 28514442 | |
| RIC8B_HUMAN | RIC8B | physical | 28514442 | |
| PPME1_HUMAN | PPME1 | physical | 28514442 | |
| MTMR4_HUMAN | MTMR4 | physical | 28514442 | |
| PGTA_HUMAN | RABGGTA | physical | 28514442 | |
| SCPDL_HUMAN | SCCPDH | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Membrane-induced folding of the cAMP-regulated phosphoproteinendosulfine-alpha."; Boettcher J.M., Hartman K.L., Ladror D.T., Qi Z., Woods W.S.,George J.M., Rienstra C.M.; Biochemistry 47:12357-12364(2008). Cited for: INTERACTION WITH SNCA, PHOSPHORYLATION AT SER-109, AND MUTAGENESIS OFSER-109. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND TYR-70, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-109; THR-112AND SER-113, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-70, AND MASSSPECTROMETRY. | |